D
Vigil Neuroscience, Inc.
VIGL
$1.77
$0.095.36%
D
Sell
3/27/2025Upgraded
Vigil Neuroscience, Inc. (VIGL) was upgraded to D- from E+ on 3/27/2025 due to an increase in the volatility index.
Vigil Neuroscience, Inc. (VIGL) was upgraded to D- from E+ on 3/27/2025 due to an increase in the volatility index.
E
Sell
2/28/2025Downgrade
Vigil Neuroscience, Inc. (VIGL) was downgraded to E+ from D- on 2/28/2025 due to a decline in the volatility index and total return index.
Vigil Neuroscience, Inc. (VIGL) was downgraded to E+ from D- on 2/28/2025 due to a decline in the volatility index and total return index.
D
Sell
2/11/2025Upgraded
Vigil Neuroscience, Inc. (VIGL) was upgraded to D- from E+ on 2/11/2025 due to an increase in the volatility index and growth index.
Vigil Neuroscience, Inc. (VIGL) was upgraded to D- from E+ on 2/11/2025 due to an increase in the volatility index and growth index.
E
Sell
1/23/2025Downgrade
Vigil Neuroscience, Inc. (VIGL) was downgraded to E+ from D- on 1/23/2025 due to a decline in the volatility index and total return index.
Vigil Neuroscience, Inc. (VIGL) was downgraded to E+ from D- on 1/23/2025 due to a decline in the volatility index and total return index.
D
Sell
1/6/2025Upgraded
Vigil Neuroscience, Inc. (VIGL) was upgraded to D- from E+ on 1/6/2025 due to an increase in the volatility index and valuation index.
Vigil Neuroscience, Inc. (VIGL) was upgraded to D- from E+ on 1/6/2025 due to an increase in the volatility index and valuation index.
E
Sell
11/25/2024Downgrade
Vigil Neuroscience, Inc. (VIGL) was downgraded to E+ from D- on 11/25/2024 due to a decline in the volatility index.
Vigil Neuroscience, Inc. (VIGL) was downgraded to E+ from D- on 11/25/2024 due to a decline in the volatility index.
D
Sell
10/3/2024Upgraded
Vigil Neuroscience, Inc. (VIGL) was upgraded to D- from E+ on 10/3/2024 due to an increase in the volatility index.
Vigil Neuroscience, Inc. (VIGL) was upgraded to D- from E+ on 10/3/2024 due to an increase in the volatility index.
E
Sell
9/18/2024Downgrade
Vigil Neuroscience, Inc. (VIGL) was downgraded to E+ from D- on 9/18/2024 due to a decline in the volatility index.
Vigil Neuroscience, Inc. (VIGL) was downgraded to E+ from D- on 9/18/2024 due to a decline in the volatility index.
D
Sell
9/3/2024Upgraded
Vigil Neuroscience, Inc. (VIGL) was upgraded to D- from E+ on 9/3/2024 due to an increase in the volatility index and total return index.
Vigil Neuroscience, Inc. (VIGL) was upgraded to D- from E+ on 9/3/2024 due to an increase in the volatility index and total return index.
E
Sell
8/15/2024Downgrade
Vigil Neuroscience, Inc. (VIGL) was downgraded to E+ from D- on 8/15/2024 due to a decline in the volatility index, growth index and total return index. EBIT declined 4.96% from -$21.42M to -$22.48M, and earnings per share declined from -$0.5002 to -$0.5233.
Vigil Neuroscience, Inc. (VIGL) was downgraded to E+ from D- on 8/15/2024 due to a decline in the volatility index, growth index and total return index. EBIT declined 4.96% from -$21.42M to -$22.48M, and earnings per share declined from -$0.5002 to -$0.5233.
D
Sell
8/5/2024Upgraded
Vigil Neuroscience, Inc. (VIGL) was upgraded to D- from E+ on 8/5/2024 due to an increase in the volatility index.
Vigil Neuroscience, Inc. (VIGL) was upgraded to D- from E+ on 8/5/2024 due to an increase in the volatility index.
E
Sell
12/19/2023Downgrade
Vigil Neuroscience, Inc. (VIGL) was downgraded to E+ from D- on 12/19/2023 due to a decline in the volatility index and total return index.
Vigil Neuroscience, Inc. (VIGL) was downgraded to E+ from D- on 12/19/2023 due to a decline in the volatility index and total return index.
D
Sell
12/4/2023Upgraded
Vigil Neuroscience, Inc. (VIGL) was upgraded to D- from E+ on 12/4/2023 due to an increase in the volatility index, total return index and valuation index.
Vigil Neuroscience, Inc. (VIGL) was upgraded to D- from E+ on 12/4/2023 due to an increase in the volatility index, total return index and valuation index.
E
Sell
11/13/2023Downgrade
Vigil Neuroscience, Inc. (VIGL) was downgraded to E+ from D- on 11/13/2023 due to a decline in the solvency index, total return index and volatility index. The quick ratio declined from 18.39 to 13.24.
Vigil Neuroscience, Inc. (VIGL) was downgraded to E+ from D- on 11/13/2023 due to a decline in the solvency index, total return index and volatility index. The quick ratio declined from 18.39 to 13.24.
D
Sell
8/24/2023Upgraded
Vigil Neuroscience, Inc. (VIGL) was upgraded to D- from E+ on 8/24/2023 due to an increase in the volatility index.
Vigil Neuroscience, Inc. (VIGL) was upgraded to D- from E+ on 8/24/2023 due to an increase in the volatility index.
E
Sell
8/9/2023Downgrade
Vigil Neuroscience, Inc. (VIGL) was downgraded to E+ from D- on 8/9/2023 due to a decline in the volatility index, total return index and solvency index. The quick ratio declined from 22.25 to 18.39.
Vigil Neuroscience, Inc. (VIGL) was downgraded to E+ from D- on 8/9/2023 due to a decline in the volatility index, total return index and solvency index. The quick ratio declined from 22.25 to 18.39.
D
Sell
8/4/2023Upgraded
Vigil Neuroscience, Inc. (VIGL) was upgraded to D- from E+ on 8/4/2023 due to an increase in the volatility index and valuation index.
Vigil Neuroscience, Inc. (VIGL) was upgraded to D- from E+ on 8/4/2023 due to an increase in the volatility index and valuation index.
E
Sell
7/20/2023Downgrade
Vigil Neuroscience, Inc. (VIGL) was downgraded to E+ from D- on 7/20/2023 due to a decline in the volatility index.
Vigil Neuroscience, Inc. (VIGL) was downgraded to E+ from D- on 7/20/2023 due to a decline in the volatility index.
D
Sell
7/3/2023Upgraded
Vigil Neuroscience, Inc. (VIGL) was upgraded to D- from E+ on 7/3/2023 due to an increase in the volatility index and total return index.
Vigil Neuroscience, Inc. (VIGL) was upgraded to D- from E+ on 7/3/2023 due to an increase in the volatility index and total return index.
E
Sell
6/13/2023Downgrade
Vigil Neuroscience, Inc. (VIGL) was downgraded to E+ from D- on 6/13/2023 due to a decline in the volatility index, solvency index and valuation index.
Vigil Neuroscience, Inc. (VIGL) was downgraded to E+ from D- on 6/13/2023 due to a decline in the volatility index, solvency index and valuation index.
D
Sell
3/14/2023Downgrade
Vigil Neuroscience, Inc. (VIGL) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
Vigil Neuroscience, Inc. (VIGL) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
D
Sell
2/1/2023Upgraded
Vigil Neuroscience, Inc. (VIGL) was upgraded to D from D- on 2/1/2023 due to an increase in the solvency index and growth index. Earnings per share increased from -$0.6044 to -$0.5255, and the quick ratio increased from 20.42 to 21.24.
Vigil Neuroscience, Inc. (VIGL) was upgraded to D from D- on 2/1/2023 due to an increase in the solvency index and growth index. Earnings per share increased from -$0.6044 to -$0.5255, and the quick ratio increased from 20.42 to 21.24.
D
Sell
10/3/2022Upgraded
Vigil Neuroscience, Inc. (VIGL) was upgraded to D- from E on 10/3/2022 due to a noticeable increase in the total return index and volatility index.
Vigil Neuroscience, Inc. (VIGL) was upgraded to D- from E on 10/3/2022 due to a noticeable increase in the total return index and volatility index.
E
Sell
7/1/2022Upgraded
Vigil Neuroscience, Inc. (VIGL) was upgraded to E from E- on 7/1/2022 due to a significant increase in the solvency index, growth index and efficiency index. The quick ratio increased from 9.25 to 24.75, earnings per share increased from -$8.2849 to -$0.5752, and total capital increased 78.68% from $93.43M to $166.95M.
Vigil Neuroscience, Inc. (VIGL) was upgraded to E from E- on 7/1/2022 due to a significant increase in the solvency index, growth index and efficiency index. The quick ratio increased from 9.25 to 24.75, earnings per share increased from -$8.2849 to -$0.5752, and total capital increased 78.68% from $93.43M to $166.95M.
E
Sell
4/18/2022None
Vigil Neuroscience, Inc. (VIGL) was downgraded to E- from U on 04/18/2022.
Vigil Neuroscience, Inc. (VIGL) was downgraded to E- from U on 04/18/2022.
NASDAQ
04/02/2025 4:00PM Eastern
Quotes delayed
